Search - tctmd.com

Displaying 881 - 900 of 1184

Sort: Relevancy | Date

News Daily News

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Yael L. Maxwell

July 11, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

Meta-analysis: Bone Marrow Cell Transplantation Effective for Ischemic Heart Disease

June 29, 2012

Presentation

Should We Still Be Concerned About Stent Thrombosis With CoCr-EES?

Presenter: 138230|Srihari Naidu

June 22, 2012

News Industry News

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

June 21, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

News Daily News

Meta Análisis: Menor Trombosis del Stent a los 2 Años con SLE que con Otro Tipo de SLF

Leah Lawrence

June 15, 2012

Presentation

Stent Thrombosis with Everolimus-Eluting Stents

Presenter: T. Palmerini

June 14, 2012

News Industry News

STENTYS starts clinical trial to broaden portfolio with new drug-eluting stent

June 14, 2012

News Daily News

VA Registry Finds Long-term Benefit from Clopidogrel Beyond 12 Months

Caitlin E. Cox

June 11, 2012

News Industry News

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

June 04, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

L.A. McKeown

June 01, 2012

News Daily News

TRITON-TIMI 38 Analysis: In CABG Patients, Mortality Benefit with Prasugrel Despite Higher Bleeding Risk

L.A. McKeown

May 29, 2012

News Industry News

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

May 25, 2012

News Daily News

JAMA Letter: Damage to DES After Balloon Expansion Documented in All 4 FDA-Approved Devices

May 25, 2012

News Daily News

Carta de JAMA: Daños en los SLF tras la Expansión del Balón Documentados en 4 Dispositivos Aprobados por la FDA

May 25, 2012

News Daily News

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

L.A. McKeown

May 23, 2012

News Daily News

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

May 22, 2012

Advertisement

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Meta-analysis: Bone Marrow Cell Transplantation Effective for Ischemic Heart Disease

Should We Still Be Concerned About Stent Thrombosis With CoCr-EES?

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Meta Análisis: Menor Trombosis del Stent a los 2 Años con SLE que con Otro Tipo de SLF

Stent Thrombosis with Everolimus-Eluting Stents

STENTYS starts clinical trial to broaden portfolio with new drug-eluting stent

VA Registry Finds Long-term Benefit from Clopidogrel Beyond 12 Months

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

TRITON-TIMI 38 Analysis: In CABG Patients, Mortality Benefit with Prasugrel Despite Higher Bleeding Risk

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

JAMA Letter: Damage to DES After Balloon Expansion Documented in All 4 FDA-Approved Devices

Carta de JAMA: Daños en los SLF tras la Expansión del Balón Documentados en 4 Dispositivos Aprobados por la FDA

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content